Petros Pharmaceuticals, Inc. (PTPI)
| Market Cap | 268.45K |
| Revenue (ttm) | 5.11M |
| Net Income (ttm) | -26.80M |
| Shares Out | 2.14M |
| EPS (ttm) | -83.47 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 6,807,361 |
| Open | 0.1456 |
| Previous Close | 0.1478 |
| Day's Range | 0.1177 - 0.1478 |
| 52-Week Range | 0.1174 - 18.0000 |
| Beta | 2.20 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | May 19, 2025 |
About PTPI
Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men’s health therapeutics in the United States and internationally. It operates through two segments, Prescription Medications and Medical Devices. The company offers men’s health products, including vacuum erection devices, PreBoost, VenoSeal, penile injections Rx, and urinary tract infection tests for the treatment of erectile dysfunction. Petros Pharmaceuticals, Inc. is based in New York, New York. [Read more]
Financial Performance
In 2024, Petros Pharmaceuticals's revenue was $5.11 million, a decrease of -12.20% compared to the previous year's $5.82 million. Losses were -$26.80 million, 94.0% more than in 2023.
Financial StatementsNews
NextTrip Secures $3 Million Line of Credit from Chairman to Support Growth and Operations
New Facility Provides Enhanced Financial Flexibility to Achieve Near-Term Strategic Initiatives and Growth Opportunities in 2025 SANTA FE, NEW MEXICO / ACCESS Newswire / May 8, 2025 / NextTrip, Inc. (...
Petros Pharmaceuticals Strengthens Partnership with Market Leading Big Data Provider Implementing Key Enhancements to its AI Platform
Company continues to innovate and develop its SaaS-based platform to facilitate Rx-to-OTC switch in line with recent President Trump Executive Order NEW YORK, NY / ACCESS Newswire / May 6, 2025 / Petr...
Petros Pharmaceuticals Developing First-in-Industry SaaS Platform Utilizing AI and Electronic Health Records Intended to Facilitate Rx-OTC Switches
Licensable platform intended to facilitate industry compliance with President Trump's recent Executive Order to expand access to medicines through OTC approvals under his Make America Healthy Again (M...
Petros Proprietary Technology Platform Aligns with April 15, 2025 President Trump Executive Order Advancing Rx-to-OTC Reclassification Reforms
Company's AI and Big Data technology positioned to drive strong industry collaboration Company also announces certain corporate actions NEW YORK, NY / ACCESS Newswire / April 29, 2025 / Petros Pharmac...
NextTrip Provides Business Update and Highlights Major Milestones in Strategic Expansion, Solidifying Positioning in Luxury and Experiential Travel
Recent Developments Bring NextTrip Closer to Delivering a True One-Stop Platform for Travelers Worldwide while Building Long-Term Value for Stakeholders Nasdaq Listing Approved and Continued Complianc...
NextTrip Completes Full Acquisition of Luxury Travel Brand Five Star Alliance with Remaining 51% Purchase
Transaction Further Strengthens NextTrip's Position in the Travel Market, Unlocking New Integration and Revenue Generating Opportunities Across Both B2C and B2B Travel Segments SANTA FE, NM / ACCESS N...
NextTrip Acquires JOURNY TV Channel, Expanding Its FAST Media Footprint
Acquisition Accelerates NextTrip Media Growth, Strengthening Audience Reach and Advertising Opportunities SANTA FE, NEW MEXICO / ACCESS Newswire / April 7, 2025 / NextTrip, Inc. (NASDAQ:NTRP) ("NextTr...
NextTrip Holdings and Intimate Hotels of Barbados Forge Strategic Partnership to Enhance Caribbean Travel Experience
NextTrip's Technology Platform will be Integrated to Provide Guests with a Streamlined and Intuitive Booking Experience SANTA FE, NM / ACCESS Newswire / April 3, 2025 / NextTrip, Inc. (NASDAQ:NTRP) ("...
NextTrip Reports Strong Growth in Group Bookings Following Five Star Alliance Collaboration
NextTrip has Secured 300 Traveler Bookings, Totaling 1,480 Room Nights, Expected to Generate Several Hundred Thousand Dollars in Revenue Upon Travel SANTA FE, NM / ACCESS Newswire / April 1, 2025 / Ne...
NextTrip Launches New Innovative Online Cruise Booking Platform NextTrip Cruise
Next-Gen Platform Provides a Seamless End-to-End Cruise Booking Process for Travelers SANTA FE, NM / ACCESS Newswire / March 27, 2025 / NextTrip, Inc. (NASDAQ:NTRP) ("NextTrip," "we," "our," or the "C...
Petros Pharmaceuticals to Partner with Renowned Big Data Provider to Enable Rx-to-OTC Switch Across Multiple Indications
Company to integrate industry leading big data technology solutions into its AI-driven platform to expand capabilities in identifying eligible patients to receive formerly Rx medications over the coun...
NextTrip Strengthens Financial Position with the Conversion of $2.6 Million in Short-Term Debt to Restricted Equity Before its Fiscal Year-End
Provides for a Stronger Balance Sheet and Greater Financial Flexibility to Focus on Scaling Innovative Travel Solutions SANTA FE, NM / ACCESS Newswire / February 28, 2025 / NextTrip, Inc. (NASDAQ:NTRP...
NextTrip and Blue Fysh Announce Strategic Partnership and Share Exchange Agreement to Drive Mutual Growth
Enables Expanded Audience Reach, Increased Advertising Revenue, Enhanced Sales Efforts, Increased Brand Awareness and Other Strategic Partnership Opportunities SUNRISE, FL / ACCESS Newswire / February...
Petros Pharmaceuticals' Proprietary Technology Demonstrates Positive Data in Pivotal Study
Proprietary technology utilizing AI and big data integrations to enable Rx to OTC switch candidates across multiple indications NEW YORK, NY / ACCESS Newswire / February 25, 2025 / Petros Pharmaceutic...
NextTrip Appoints John McMahon as Chief Operating Officer - Travel, Expands into Cruise Industry with Five Star Alliance
Proven Industry Leader Brings Deep Relationships and Extensive Expertise Across all Facets of Leisure, Travel and Tourism Five Star Alliance Now Directing Group Booking Inquiries to NextTrip NextTrip ...
Petros Pharmaceuticals Announces Pricing of $9.6 Million Public Offering of Common Stock and Warrants
NEW YORK, NY / ACCESS Newswire / February 18, 2025 / Petros Pharmaceuticals, Inc. (NASDAQ:PTPI) ("Petros" or the "Company"), a company focused on expanding consumer access to medication through over-t...
NextTrip Closes on 49% Stake in Five Star Alliance
Secures Option to Acquire Full Ownership SANTA FE, NM / ACCESS Newswire / February 11, 2025 / NextTrip, Inc. (NASDAQ:NTRP) ("NextTrip" or the "Company"), a leading travel technology company, today ann...
NextTrip Invests in Luxury Travel Brand Five Star Alliance to secure 49% Stake with an Option to Purchase a Controlling Interest
Transaction Expected to Strengthen NextTrip's Platform, Unlocks New Integration and Growth Opportunities Five Star Senior Management to Join NextTrip to Help Define Key Areas of Synergy and Revenue Ac...
Petros Pharmaceuticals Strategically Positioned to Benefit as Technology Leader from Newly Approved FDA OTC Final Rules
Proprietary technology developing quantum computing and applying AI to better enable Rx to OTC switch candidates across multiple indications NEW YORK, NY / ACCESSWIRE / January 7, 2025 / Petros Pharma...
Petros Pharmaceuticals Featured in “New Era of Healthcare, AI, Data and Consumer Empowerment”
Company positions itself for new innovation utilizing AI and quantum computing to help expand patient access to drugs via OTC access NEW YORK, NY / ACCESSWIRE / December 19, 2024 / Petros Pharmaceutic...
Proprietary Technology Addressing the Rx-to-OTC Switch Self-Care Market Valued at over $38 Billion annually
Working to identify quantum computing partnerships to strengthen our AI technology to include critical health records to better enable Rx to OTC switch candidates across multiple indications NEW YORK,...
NextTrip Launches Advertising on Compass.tv in Collaboration with Leap Media Group
NextTrip, Inc. (NASDAQ:NTRP) ("NextTrip," "we," "our," or the "Company"), a leading travel technology company, today announced the official launch of advertising on its travel discovery channel, Compa...
NextTrip Plans to Acquire Luxury Travel Company Five Star Alliance
One of Trustpilot's Top-rated Travel Brands Brings its Proprietary Search Engine, Luxury Cruise Program, and Group Travel Pipeline, Along with Access to Additional Travel Agencies Acquisition is Highl...
NextTrip Prepares Compass.tv for Soft Launch, Signs New Content Creators
Seamlessly Translates Content into Commerce Opportunities using the NextTrip Booking Engine SANTA FE, NM / ACCESSWIRE / October 1, 2024 / NextTrip, Inc. (NASDAQ:NTRP) ("NextTrip," "we," "our," or the ...
Petros Pharmaceuticals Executes Successful Initial Test for App Comprehension as Part of FDA Pathway for Over-the-Counter Access for STENDRA(R) (avanafil)
Company is currently conducting larger scale comprehension test to confirm results in compliance with FDA discussions NEW YORK, NY / ACCESSWIRE / September 11, 2024 / Petros Pharmaceuticals, Inc. (NAS...